BioNxt Solutions Inc.
BioNxt Solutions Inc. (BNXT.CN) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
bnxt.cn · pe ratio · data through Dec 31, 2025
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for BioNxt Solutions Inc. (BNXT.CN) measures how much investors pay for each dollar of the company's trailing earnings. BNXT.CN's current PE ratio of N/A is calculated by dividing its stock price of $0.41 by its TTM earnings per share of -$0.07.
Source: FMP · /ratios-ttm · /analyst-estimates · 2025-12-31
PE Ratio History
2017 – 2025 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
PE Ratio vs Peers
Drug Manufacturers - Specialty & Generic · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
BioNxt Solutions Inc.You BNXT.CN | $53M | N/A | — | -$0.07 |
 Cardiol Therapeutics Inc. CRDL.TO | $169M | N/A | — | -$0.39 |
 C21 Investments Inc. CXXI.CN | $48M | N/A | — | -$0.03 |
 Decibel Cannabis Company Inc. DB.V | $66M | N/A | — | -$0.01 |
 InnoCan Pharma Corporation INNO.CN | $15M | N/A | — | -$0.25 |
 Medicenna Therapeutics Corp. MDNA.TO | $30M | N/A | — | -$0.15 |
 Medexus Pharmaceuticals Inc. MDP.TO | $128M | 27.81x | — | $0.09 |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2025-12-31Latest FY2025 | — | $-0.06 | — | |
2024-12-31 FY2024 | — | $-0.05 | — | |
2023-12-31 FY2023 | — | $-0.08 | — | |
2022-12-31 FY2022 | — | $-0.15 | — | |
2021-12-31 FY2021 | — | $-0.29 | — | |
2020-12-31 FY2020 | — | $-0.30 | — | |
2019-12-31 FY2019 | — | $-0.15 | — | |
2018-12-31 FY2018 | — | $-0.02 | — | |
2017-12-31 FY2017 | — | $-0.00 | — |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for BioNxt Solutions Inc. (BNXT.CN) measures how much investors pay for each dollar of the company's trailing earnings. BNXT.CN's current PE ratio of N/A is calculated by dividing its stock price of $0.41 by its TTM earnings per share of -$0.07.
Frequently asked questions
BNXT.CN pe ratio · 6 questionsBNXT.CN's current PE ratio is N/A as of 2026-06-08, based on a stock price of $0.41 and TTM EPS of -$0.07. Data sourced from Financial Modeling Prep via BNXT.CN's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · BioNxt Solutions Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-08